Výsledky vyhledávání - "Yulia Abugova"

Blinatumomab following haematopoietic stem cell transplantation – a novel approach for the treatment of acute lymphoblastic leukaemia in infants

Autor: Alexander Popov, Grigory Tsaur, Yulia Abugova, Galina Novichkova, Natalia Miakova, Dmitry Balashov, Veronika Fominikh, Larisa Shelikhova, Alexey Maschan, Elena Zerkalenkova, Ekaterina Mikhailova, Yulia Olshanskaya

Publikováno v: British Journal of Haematology. 194:174-178

Blinatumomab with subsequent haematopoietic stem cell transplantation was applied in 13 infants with acute lymphoblastic leukaemia (ALL). Eight patients were treated in first remission due to slow clearance of minimal residual disease (MRD); one for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ae48092c80b263ba8ad2889ab119bc
https://doi.org/10.1111/bjh.17466

Zobrazit plný text záznamu

Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second Russian‐Belorussian multicentre study B‐ NHL ‐2010M

Autor: Margarita B. Belogurova, Lebedev Vv, Alina Fedorova, N.V. Myakova, Natalia Ponomareva, Olga Aleinikova, Elena Samochatova, Natalia Grigor'eva, Nadezhda Smirnova, Egor Volchkov, Olga Nikonova, Guzel Sharapova, Alexey Maschan, Yulia Abugova, Larisa Fechina, Anastassia Shamardina, Anastassia Rudneva

Publikováno v: British Journal of Haematology. 186:477-483

The value of adding rituximab to chemotherapy in children with aggressive B-cell non-Hodgkin lymphoma (B-NHL) is still insufficiently studied. We enrolled 231 patients [mean age 9 years old (range 2-17); male:female ratio 3·4:1] with Burkitt (BL, 17

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ffb020209516c5bdb0af259d1edab3
https://doi.org/10.1111/bjh.15944

Zobrazit plný text záznamu

Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion

Autor: Nadezhda Smirnova, N.V. Myakova, Yulia Abugova, Y.V. Skvortsova, Dmitry Evstratov, Dmitry Balashov, Alexey Maschan, Dmitry Konovalov, Yulia Diakonova

Publikováno v: Clinical Case Reports

Key Clinical Message Treatment of patients with refractory Hodgkin lymphoma is a significant issue. We report a patient with Proteus syndrome and relapsed Hodgkin lymphoma, whose remission was finally achieved after brentuximab vedotin therapy, allow

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0ae49a33d389c8b01e4852fd149503b
http://europepmc.org/articles/PMC4527816

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání